Jill A. Howe - 05 Mar 2026 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role: Chief Financial Officer
Signature: /s/ Jill A. Howe
Issuer symbol: LCTX
Transactions as of: 05 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Mar 2026, 19:50:33 UTC
Previous filing: 12 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Howe Jill Ann	Chief Financial Officer	C/O LINEAGE CELL THERAPEUTICS, 2173 SALK AVENUE, SUITE 200, CARLSBAD	/s/ Jill A. Howe	06 Mar 2026	0001892397

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LCTX	Employee Stock Option (Right to Buy)	Award		+1,050,000		$0.000000^*	1,050,000	05 Mar 2026	Common Shares	1,050,000	$1.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One quarter of the options shall vest on March 5, 2027, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.